CLAIM CARD
The evidence uncovers a telomere length paradox where genetically determined elongation concurrently reduces coronary heart disease risk but elevates cancer susceptibility in the same elderly cohort, with effect sizes modulated by genetic variants, measurement methodology, and tissue-specific contexts—a nuanced framework that challenges simplistic aging narratives and highlights intervention trade-offs.
Evidence grade: exploratory
Contradiction status: none
Publication: 71ec06d6-beed-42bc-a0b2-b14053a14f0b
Provenance: Derivation Web chain
Citation Support
source_1Telomere length and brain aging: A systematic review and meta-analysissource_2Telomere Length and All-Cause Mortality: A Meta-analysissource_3The Association of Telomere Length in Peripheral Blood Cells with Cancer Risk: A Systematic Review and Meta-analysis of Prospective Studiessource_4Telomere length and aging‐related outcomes in humans: A Mendelian randomization study in 261,000 older participantssource_5Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis